Division of Pediatric Hematology/Oncology, Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Lancet Oncol. 2021 May;22(5):e196-e206. doi: 10.1016/S1470-2045(20)30688-4. Epub 2021 Apr 9.
Exposure to cranial radiotherapy is associated with an increased risk of subsequent CNS neoplasms among childhood, adolescent, and young adult (CAYA) cancer survivors. Surveillance for subsequent neoplasms can translate into early diagnoses and interventions that could improve cancer survivors' health and quality of life. The practice guideline presented here by the International Late Effects of Childhood Cancer Guideline Harmonization Group was developed with an evidence-based method that entailed the gathering and appraisal of published evidence associated with subsequent CNS neoplasms among CAYA cancer survivors. The preparation of these guidelines showed a paucity of high-quality evidence and highlighted the need for additional research to inform survivorship care. The recommendations are based on careful consideration of the evidence supporting the benefits, risks, and harms of the surveillance interventions, clinical judgment regarding individual patient circumstances, and the need to maintain flexibility of application across different health-care systems. Currently, there is insufficient evidence to establish whether early detection of subsequent CNS neoplasms reduces morbidity and mortality, and therefore no recommendation can be formulated for or against routine MRI surveillance. The decision to start surveillance should be made by the CAYA cancer survivor and health-care provider after careful consideration of the potential harms and benefits of surveillance for CNS neoplasms, including meningioma.
颅放射治疗会增加儿童、青少年和青年期(CAYA)癌症幸存者发生中枢神经系统(CNS)肿瘤的风险。对继发肿瘤的监测可以转化为早期诊断和干预,从而改善癌症幸存者的健康和生活质量。本国际儿童癌症晚期效应指南协调小组制定的实践指南采用了循证方法,即收集和评估与 CAYA 癌症幸存者继发 CNS 肿瘤相关的已发表证据。制定这些指南表明高质量证据不足,并强调需要开展更多研究为生存护理提供信息。这些建议是基于仔细考虑支持监测干预的获益、风险和危害的证据、对个体患者情况的临床判断,以及在不同医疗保健系统中保持应用灵活性的需要。目前,尚无足够证据表明早期发现继发 CNS 肿瘤可降低发病率和死亡率,因此,不能制定常规 MRI 监测的推荐或反对意见。是否开始监测应在 CAYA 癌症幸存者和医疗保健提供者仔细考虑 CNS 肿瘤(包括脑膜瘤)监测的潜在危害和获益后做出决定。